Jung Sehyun, Lee Soojin, Kim Yaerim, Cho Semin, Huh Hyuk, Kim Yong Chul, Han Seung Seok, Lee Hajeong, Lee Jung Pyo, Joo Kwon Wook, Lim Chun Soo, Kim Yon Su, Kim Dong Ki, Han Kyungdo, Park Sehoon
Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Republic of Korea.
Department of Internal Medicine, Uijeongbu Eulji University Medical Center, Uijeongbu, Republic of Korea.
Kidney Res Clin Pract. 2024 Mar;43(2):202-215. doi: 10.23876/j.krcp.22.088. Epub 2024 Mar 20.
Further study is warranted to determine the association between estimated glomerular filtration rate (eGFR) or albuminuria and the risk of death from diverse causes.
We screened >10 million general health screening examinees who received health examinations conducted in 2009 using the claims database of Korea. After the exclusion of those previously diagnosed with renal failure and those with missing data, 9,917,838 individuals with available baseline kidney function measurements were included. The primary outcome was mortality and cause-specific death between 2009 and 2019 identified through death certificates based on the diagnostic codes of International Classification of Diseases, 10th revision. Multivariable Cox regression analysis adjusted for various clinicodemographic and social characteristics was used to assess mortality risk.
The hazard ratio of death was significantly high in both the eGFR <60 mL/min/1.73 m2 and in the eGFR ≥120 mL/ min/1.73 m2 groups in univariable and multivariable regression analyses when compared to those within the reference range (eGFR of 90-120 mL/min/1.73 m2). The results were similar for death by cardiovascular, cancer, infection, endocrine, respiratory, and digestive causes. We also found that albuminuria was associated with higher risk of death regardless of eGFR range, and those in the higher categories of dipstick albuminuria showed higher risk.
We reconfirmed the significant association between eGFR, albuminuria, and mortality. Healthcare providers should keep in mind that albuminuria and decreased eGFR as well as kidney hyperfiltration are independent predictors of mortality.
有必要进行进一步研究以确定估算肾小球滤过率(eGFR)或蛋白尿与各种原因导致的死亡风险之间的关联。
我们利用韩国的理赔数据库,对2009年接受健康检查的超过1000万普通健康筛查受检者进行了筛查。在排除先前被诊断为肾衰竭的患者和数据缺失的患者后,纳入了9917838名有可用基线肾功能测量值的个体。主要结局是根据国际疾病分类第10版诊断代码通过死亡证明确定的2009年至2019年期间的死亡率和特定原因死亡。使用针对各种临床人口统计学和社会特征进行调整的多变量Cox回归分析来评估死亡风险。
在单变量和多变量回归分析中,与参考范围内(eGFR为90 - 120 mL/min/1.73 m²)的个体相比,eGFR <60 mL/min/1.73 m²组和eGFR≥120 mL/min/1.73 m²组的死亡风险比均显著更高。心血管、癌症、感染、内分泌、呼吸和消化系统原因导致的死亡结果相似。我们还发现,无论eGFR范围如何,蛋白尿都与较高的死亡风险相关,尿试纸蛋白尿分类较高的个体风险更高。
我们再次证实了eGFR、蛋白尿与死亡率之间的显著关联。医疗服务提供者应牢记,蛋白尿、eGFR降低以及肾脏高滤过是死亡率的独立预测因素。